Black Diamond Financial, LLC

Position in CAPR — Capricor Therapeutics, Inc.

CIK 1759236 TOWSON, MD

Position in CAPR

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$2,403,940

+$121,778 QoQ

Shares Held

79,077

0.0% QoQ

Ownership

0.137%

of shares outstanding

% of Portfolio

2.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Black Diamond Financial, LLC holds $2,710,023 across 3 Biotechnology names. CAPR ranks #1 (88.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CAPR	Capricor Therapeutics, Inc. This page	79,077	$2,403,940
2	CORT	Corcept Therapeutics Inc	7,200	$290,232
3	DYAI	Dyadic International Inc	19,331	$15,851

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,403,940	79,077	0.0%	Shares	Sole	2026-05-05
2025-12-31	$2,282,162	79,077	-71.5%	Shares	Sole	2026-02-03
2025-09-30	$2,002,483	277,737	0.0%	Shares	Sole	2025-11-05
2025-06-30	$2,757,928	277,737	0.0%	Shares	Sole	2025-07-30
2025-03-31	$2,635,724	277,737	0.0%	Shares	Sole	2025-04-30
2024-12-31	$3,832,770	277,737	—	Shares	Sole	2025-02-04
No filing history on record for this holder in this stock.